Sam A. Samad serves as the Executive Vice President and Chief Financial Officer at Quest Diagnostics Incorporated, a leading provider of diagnostic information services. With a robust financial background, Samad has been instrumental in steering the company's financial strategies and ensuring its growth and stability. He joined Quest Diagnostics in 2013 and has since been a pivotal part of the executive team, overseeing all aspects of the company's financial operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. Prior to his role at Quest Diagnostics, Samad held various senior financial positions at several prominent organizations. He spent over a decade at Bristol-Myers Squibb, where he progressed through roles of increasing responsibility, ultimately serving as the Senior Vice President and Corporate Controller. His tenure at Bristol-Myers Squibb was marked by significant contributions to the company's financial health and strategic initiatives. Samad's expertise in financial management and strategic planning has been a key asset to Quest Diagnostics, where he has successfully navigated the company through various market challenges and opportunities. In his current role, Samad is responsible for guiding Quest Diagnostics' financial strategy to support the company's long-term goals. His leadership has been crucial in driving the company's focus on innovation and operational excellence. Under his guidance, Quest Diagnostics has continued to expand its service offerings and enhance its financial performance, solidifying its position as a leader in the diagnostic industry. Samad's strategic vision and financial acumen continue to play a vital role in the company's ongoing success.